Virbac USA

News

Latest Announcements

MUTTS Canine Cantina

03/30/2022

Join us at MUTTS Canine Cantina for an exciting event sponsored by VETERINARY HPM® Pet Nutrition!

Read more

Virbac enters pet nutrition with a unique food tailor-made for spayed & neutered cats and dogs

02/07/2022

We are delighted to share that we have launched VETERINARY HPM® Spay & Neuter Diets in the U.S. market. Veterinary HPM Pet Nutrition is a unique nutritional line tailored to meet the needs of spayed and neutered pets throughout life.

Read more

Virbac announces the approval of its first pharmaceutical for Swine and Cattle in the U.S. and a collaboration with Pharmgate

12/07/2021

Westlake, TX / Wilmington, NC - Virbac is proud to announce the launch of its first product in the U.S. food production animal market with the FDA approval of Tulissin® 25 (tulathromycin injection) injectable solution and Tulissin® 100 (tulathromycin injection) injectable solution for use in cattle and swine. The product will be available in two concentrations: 100 mg/mL and 25 mg/mL to properly cover the two segments. Tulissin 100 injectable solution will be available in 500, 250, 100 and 50 mL bottles and Tulissin 25 Injectable Solution in 250 and 100 mL bottles.

 

Read more

Virbac Launches its C.E.T.® Dental Authority Certification Program

11/10/2021

As an innovator in pet dental health products, Virbac recently launched its new C.E.T.® Dental Authority Certification Program, alongside Mary L. Berg, BS, RVT, RLATG, VTS (Dentistry) to help veterinarians and their healthcare teams better protect their patients' smiles. It is a free, online, self-paced program that educates users on the importance of preventative dental care in pets and how a comprehensive dental protocol can benefit both clients and clinics. The program also provides helpful tips on educating the client and facilitating those important dental discussions.

Access the Dental Authority Certification Program Here

Read more

Virbac announces the approval of Stelfonta​® (tigilanol tiglate injection)

11/23/2020

Virbac announces the approval of Stelfonta (tigilanol tiglate injection), an innovative intratumoral injection treatment for canine mast cell tumors

Read more